Suvretta Capital Management, LLC Heron Therapeutics, Inc. Transaction History

Suvretta Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $1.18 Million - $2.38 Million	-444,048 Reduced 13.66%	2,807,000 $11.8 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $878,599 - $2.4 Million	382,000 Added 13.31%	3,251,048 $9.07 Million
Q1 2022 May 16, 2022	BUY	$4.63 - $9.94 $1.77 Million - $3.8 Million	382,708 Added 15.39%	2,869,048 $16.4 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $8.32 Million - $12.5 Million	995,900 Added 66.82%	2,486,340 $22.7 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $13.1 Million - $18.2 Million	984,403 Added 194.53%	1,490,440 $23.1 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $7.33 Million - $10.5 Million	506,037 New	506,037 $8.2 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $441,045 - $869,535	-40,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $414,315 - $994,680	40,500 New	40,500 $475,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.